Anthony Samir, M.D., MBBCH


Physician Investigator (Cl)
Radiology, Mass General Research Institute
Assistant Professor of Radiology
Harvard Medical School
Radiologist
Radiology, Massachusetts General Hospital
MPH 2013
MB BCH University of Witwatersrand 1996
autoimmune liver disease; carcinoma hepatocellular; carcinoma renal cell; cathartics; catheter ablation; echinococcosis hepatic; echinococcus granulosus; elastic modulus; elasticity imaging techniques; interventional radiology; kidney neoplasms; liver diseases; machine learning; quantitative imaging; radiographic image enhancement; radiology; splenic diseases; statistics as topic; thyroid diseases; thyroid neoplasms; thyroid nodule; ultrasonography; ultrasonography interventional; ultrasound elastography; ureteral diseases

Dr. Anthony Samir is an Assistant Professor at Harvard Medical School, and a Diagnostic and Interventional Radiologist at the Massachusetts General Hospital, where he serves as Service Chief for Body Ultrasound Imaging Services. He trained as a MD general practitioner in South Africa, followed by advanced post-graduate training in Internal Medicine and Surgery in New Zealand and Australia, and a five year-residency in Diagnostic and Interventional Radiology in Australia. He completed additional training in medical informatics, followed by two one year subspecialty fellowships in Abdominal Imaging and Interventional Radiology at the Massachusetts General Hospital. He joined the faculty of MGH Radiology and Harvard Medical School in 2006, and then completed a Masters degree in Public Health at the Harvard School of Public Health, with a concentration in the techniques and methods to measure the effectiveness of technology in healthcare settings. 

In addition to actively seeing patients, Dr. Samir currently works in several domains: (1) Imaging biomarker development and clinical trials: Dr. Samir is an internationally recognized expert in the field of non-invasive diffuse liver disease staging. His research group pioneered widely-used diagnostic assessments for liver fibrosis, and he currently chairs the 32-member clinical subcommittee of the Radiological Society of North America concerned with ultrasonic liver fibrosis staging. Dr. Samir has led two major prospective clinical trials of ultrasound elastography for liver disease and thyroid disease, and is an author of the Uniform Protocol for Imaging in Clinical Trials for ultrasound elastography. (2) Mentorship and education: Dr. Samir is co-editor of Abdominal imaging, a widely used two-volume subspecialty reference text, and is the author or co-author of more than 20 educational book chapters. He has mentored more than thirty post-doctoral fellows, most of whom have gone on to successful academic and clinical careers. (3) Technology development: Dr. Samir co-founded the MGH Clinical Ultrasound Research Laboratory and the MGH/MIT Center for Ultrasound Research & Translation, a joint center focused on rapid innovation and tight integration of engineering and iterative clinical refinement. In these leadership roles, together with collaborators, he has developed a number of medical imaging and image-guided interventional technologies, and has acquired extensive experience innovating successfully in partnership with other academic groups and industry.  He has a strong interest in clinical applications and integration of predictive analytics and machine learning models into medical devices. He has received numerous collaborative foundation and government grants and industry funding and support from almost every major medical device company. His awards include the Far Eastern Economic Review Young Inventors Prize, the Siemens Australia Research prize, and the ABC Television Inventor’s Prize.